Daniel Handley
Director/Board Member bei PREDICTIVE ONCOLOGY INC.
Vermögen: 47 586 $ am 31.03.2024
Profil
Daniel E.
Handley is currently the Director at Translational Genomics Research Institute since 2019.
He is also an Independent Director at Predictive Oncology, Inc. since 2020 and a Professor at Southern California University of Health Sciences since 2019.
Previously, he worked as a Laboratory Manager at David Geffen School of Medicine from 1991 to 1994.
He also served as the Chief Scientific Officer at Life-SEQ LLC and Advanced Healthcare Technology Solutions, Inc. from 2010 to 2013.
Dr. Handley holds a graduate degree from Carnegie Mellon University, a doctorate from the University of Pittsburgh, and an undergraduate degree from The Johns Hopkins University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PREDICTIVE ONCOLOGY INC
0,46% | 05.04.2024 | 18 661 ( 0,46% ) | 47 586 $ | 31.03.2024 |
Aktive Positionen von Daniel Handley
| Unternehmen | Position | Beginn |
|---|---|---|
| PREDICTIVE ONCOLOGY INC. | Director/Board Member | 19.02.2020 |
| Southern California University of Health Sciences | Corporate Officer/Principal | 01.04.2019 |
Translational Genomics Research Institute
 Translational Genomics Research Institute Miscellaneous Commercial ServicesCommercial Services Translational Genomics Research Institute operates as non-profit organization. It focuses on developing earlier diagnoses and smarter treatments. Translational research applies to the development of diagnostics, prognostics, and therapies for cancer, neurological disorders, diabetes, and other complex diseases. The company was founded by Jeffrey M. Trent in 2002 and is headquartered in Phoenix, AZ. | Director/Board Member | 01.04.2019 |
Ehemalige bekannte Positionen von Daniel Handley
| Unternehmen | Position | Ende |
|---|---|---|
| Advanced Healthcare Technology Solutions, Inc. | Chief Tech/Sci/R&D Officer | 01.01.2013 |
| David Geffen School of Medicine | Corporate Officer/Principal | 01.01.1994 |
Life-SEQ LLC
 Life-SEQ LLC Miscellaneous Commercial ServicesCommercial Services Life-SEQ LLC provides health care professional training, logistics, consulting, and telemedicine support services. The private company is based in Boston, MA. The company was founded by Timothy Adam Krochuk and Gregory S. St. Clair. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Daniel Handley
| Carnegie Mellon University | Graduate Degree |
| University of Pittsburgh | Doctorate Degree |
| The Johns Hopkins University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PREDICTIVE ONCOLOGY INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Translational Genomics Research Institute
Translational Genomics Research Institute Miscellaneous Commercial ServicesCommercial Services Translational Genomics Research Institute operates as non-profit organization. It focuses on developing earlier diagnoses and smarter treatments. Translational research applies to the development of diagnostics, prognostics, and therapies for cancer, neurological disorders, diabetes, and other complex diseases. The company was founded by Jeffrey M. Trent in 2002 and is headquartered in Phoenix, AZ. | Commercial Services |
Life-SEQ LLC
Life-SEQ LLC Miscellaneous Commercial ServicesCommercial Services Life-SEQ LLC provides health care professional training, logistics, consulting, and telemedicine support services. The private company is based in Boston, MA. The company was founded by Timothy Adam Krochuk and Gregory S. St. Clair. | Commercial Services |
| Advanced Healthcare Technology Solutions, Inc. |
